Key factors
symJAN
exchUS
MCap13.03M
Beta2.176
PE Ratio29.22
EPS0.09
Div date0000-00-00
Yesterday
symJAN
exchUS
close2.63
50 Day MA0.833
200 Day MA0.715
52 Week High3.087
52 Week Low0.220
Target Price 4.0
Market Cap Mln13.03
Share statistics
Shares Outstanding4957.65K
Shares Float4174.54K
Percent Institutions9.213
PercentInsiders11.45
SharesShort268.14K
Short Ratio0.79
Shares Short Prior Month22876
Short Percent6.109
Revenue TTM 39.61M
Revenue Per Share TTM 11.14
Quarterly Revenue Growth YOY -29.1
Gross Profit TTM 7619.0K
EBITDA-3501.0K
Diluted Eps TTM0.09
Quarterly Earnings Growth YOY-98.9
earning
Operating Margin TTM -0.12
Trailing PE 29.22
Earnings Share 0.09
Dividend
Dividend Date2019-04-22
Last Split Date 2019-04-22
Last Split Factor1:5
business
Enterprise Value Ebitda -6.83
Enterprise Value Revenue0.322
Book Value /share 2.924
Price Book MRQ 0.899
Price Sales TTM 0.329
ProfitMargin 0.325
ReturnOnAssetsTTM -0.10
ReturnOnEquityTTM0.010
Gic GroupCommercial & Professional Services
Gic IndustryCommercial Services & Supplies
Gic Sector Industrials
IndustryWaste Management
SectorIndustrials
ISIN US47089W1045
CIK 862861
Code JAN
CUSIP 03814F106
CountryISO US
Currency CodeUSD
Currency Name US Dollar
Exchange NASDAQ
Currency Symbol $
Type Common Stock
UpdatedAt 2024-03-08
Home Category Domestic
Fiscal Year End December
Full Time Employees199.0
IPODate 1991-11-07
MostRecent Quarter2023-09-30
Contact
NameJanone Inc
Address325 East Warm Springs Road, Las Vegas, NV, United States, 89119
Country NameUSA
Phone702 997 5968
Web URLhttps://www.janone.com
Logo URL/img/logos/US/JAN.png
JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through Biotechnology and Recycling segments. The company's lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease to treat pain. It also provides turnkey appliance recycling and replacement services for utilities and other sponsors of energy efficiency programs. The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019. JanOne Inc. was founded in 1976 and is headquartered in Las Vegas, Nevada.